Related Experiment Video
Updated: Apr 11, 2026
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.8K
Percutaneous Mechanical Support in Cardiogenic Shock: A Review
Fahad Syed Gilani1, Sarah Farooqui1, Rajiv Doddamani1
1Division of Cardiovascular Medicine, Boston University School of Medicine, Boston Medical Center. Boston, MA, USA.
Clinical Medicine Insights. Cardiology
|June 9, 2015
Summary
Cardiogenic shock (CS) requires advanced treatment. This review covers percutaneous mechanical support devices, their evidence, and new technologies for managing this critical condition.
Area of Science:
- Cardiology
- Interventional Cardiology
- Critical Care Medicine
Background:
- Cardiogenic shock (CS) presents significant mortality and morbidity.
- Pharmacological treatments are primary, but mechanical support is crucial for refractory cases.
Purpose of the Study:
- To review available percutaneous mechanical support devices for CS.
- To examine the evidence supporting their use.
- To discuss emerging percutaneous technologies for CS treatment.
Main Methods:
- Literature review of percutaneous mechanical support devices.
- Analysis of clinical evidence for device efficacy in CS.
- Overview of current and future percutaneous technologies.
Main Results:
- Percutaneous devices offer minimally invasive hemodynamic support for failing myocardium.
- Evidence supports the use of these devices in refractory CS.
- New technological advancements are expanding treatment options.
Conclusions:
- Percutaneous mechanical support is vital for refractory cardiogenic shock.
- Ongoing innovation in percutaneous technology promises improved outcomes for CS patients.
Related Concept Videos
01:24Blood Pressure Imbalances and Circulatory Shock
1.9K
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.9K
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
1.4K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.4K
01:30Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
01:28Acute Coronary Syndrome IV: Interprofessional Care
487
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
487
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
754
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
754